We are live on !
Find out more
Thrive Capital Management (Pennsylvania) Portfolio holdings
AUM
$557M
Turnover
13.83%
1-Year Est. Return
16.31%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+16.31%
3 Year Est. Return
+65.3%
5 Year Est. Return
+56.2%
10 Year Est. Return
–
AUM
$557M
AUM Growth
+$27M
(+5.1%)
Cap. Flow
+$28.8M
Cap. Flow % of AUM
Cap. Flow %
5.17%
Top 10 Holdings %
Top 10 Hldgs %
27.36%
Holding
188
New
18
Increased
105
Reduced
54
Closed
8
Avg Time Held
1.5
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cincinnati Financial
CINF
|
+$4.66M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$4.6M |
| 3 |
Fortinet
FTNT
|
+$4.55M |
| 4 |
Allstate
ALL
|
+$4.51M |
| 5 |
McKesson
MCK
|
+$4.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$5.36M |
| 2 |
Kimberly-Clark
KMB
|
+$5.02M |
| 3 |
Merit Medical Systems
MMSI
|
+$4.81M |
| 4 |
Elanco Animal Health
ELAN
|
+$4.58M |
| 5 |
Halozyme
HALO
|
+$1.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.76% |
| 2 | Technology | 13.89% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 6.76% |
| 5 | Consumer Staples | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Invesco QQQ Trust
QQQ
$483B
| $28.5M | 5.11% |
38,514
-598
| -2% | -$427K |
2023 Q2
13 quarters
|
|
|
2
Vanguard Morningstar Value ETF
VTV
$195B
| $18.1M | 3.25% |
83,930
+20,704
| +33% | +$4.6M |
2025 Q2
5 quarters
|
|
3
Vanguard S&P 500 ETF
VOO
$1.04T
| $18M | 3.23% |
25,658
+4,597
| +22% | +$3.21M |
2025 Q2
5 quarters
|
|
4
Vanguard FTSE Developed Markets ETF
VEA
$231B
| $17.5M | 3.13% |
247,216
+25,946
| +12% | +$1.86M |
2024 Q1
10 quarters
|
|
5
Vanguard Morningstar Growth ETF
VUG
$227B
| $14.2M | 2.55% |
157,541
-16,259
| -9% | -$1.42M |
2025 Q2
5 quarters
|
|
6
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.6B
| $13.1M | 2.35% |
67,010
+20,330
| +44% | +$4.16M |
2025 Q2
5 quarters
|
|
7
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.2B
| $12M | 2.15% |
51,875
+10,688
| +26% | +$2.61M |
2025 Q2
5 quarters
|
|
8
Vanguard FTSE Emerging Markets ETF
VWO
$120B
| $10.9M | 1.96% |
184,469
-23,467
| -11% | -$1.4M |
2025 Q2
5 quarters
|
|
9
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.9B
| $10.5M | 1.89% |
31,210
-4,337
| -12% | -$1.51M |
2025 Q2
5 quarters
|
|
10
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.39B
| $9.7M | 1.74% |
522,270
+8,581
| +2% | +$156K |
2024 Q2
9 quarters
|
|
11
Advanced Micro Devices
AMD
$925B
| $8.99M | 1.61% |
14,700
+1,967
| +15% | +$1.01M |
2025 Q1
6 quarters
|
|
12
NVIDIA
NVDA
$5.16T
| $8.61M | 1.55% |
37,710
+3,195
| +9% | +$685K |
2023 Q1
14 quarters
|
|
13
Global X Russell 2000 Covered Call ETF
RYLD
$1.31B
| $8.06M | 1.45% |
520,887
+15,395
| +3% | +$247K |
2025 Q2
5 quarters
|
|
14
Global X S&P 500 Covered Call ETF
XYLD
$3.39B
| $7.9M | 1.42% |
190,310
+4,461
| +2% | +$184K |
2025 Q2
5 quarters
|
|
15
Microsoft
MSFT
$3.94T
| $6.97M | 1.25% |
13,582
+105
| +0.8% | +$48.6K |
2020 Q4
23 quarters
|
|
16
Vanguard Real Estate ETF
VNQ
$37.7B
| $6.91M | 1.24% |
77,084
+18,381
| +31% | +$1.78M |
2025 Q2
5 quarters
|
|
17
Meta Platforms (Facebook)
META
$1.63T
| $6.72M | 1.2% |
9,262
+1,123
| +14% | +$701K |
2025 Q1
6 quarters
|
|
18
Johnson & Johnson
JNJ
$662B
| $6.45M | 1.16% |
24,345
-2,083
| -8% | -$550K |
2020 Q4
23 quarters
|
|
19
Micron Technology
MU
$1.06T
| $6.42M | 1.15% |
6,028
+980
| +19% | +$931K |
2025 Q4
3 quarters
|
|
20
Amplify CEF High Income ETF
YYY
$664M
| $6.17M | 1.11% |
594,722
+32,231
| +6% | +$362K |
2024 Q1
10 quarters
|
|
21
Apple
AAPL
$5.09T
| $6.07M | 1.09% |
18,222
+2,384
| +15% | +$766K |
2020 Q4
23 quarters
|
|
22
Alphabet (Google) Class A
GOOGL
$3.49T
| $5.79M | 1.04% |
16,837
+2,650
| +19% | +$920K |
2024 Q2
9 quarters
|
|
23
JPMorgan Equity Premium Income ETF
JEPI
$46.4B
| $5.49M | 0.99% |
97,719
+11,685
| +14% | +$667K |
2024 Q1
10 quarters
|
|
24
Broadcom
AVGO
$1.65T
| $5.43M | 0.97% |
15,451
+3,000
| +24% | +$1.13M |
2023 Q4
11 quarters
|
|
25
Eli Lilly
LLY
$1.22T
| $5.16M | 0.93% |
4,462
+106
| +2% | +$125K |
2025 Q1
6 quarters
|
|
Similar funds
PHC
SCM
Thrive Capital Management (Pennsylvania)'s Q3 2026 Portfolio in Review
As of Q3 2026, Thrive Capital Management (Pennsylvania) held 188 positions worth $557M, up 5.1% from $530M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Thrive Capital Management (Pennsylvania) deployed $28.8M of net new capital in Q3 2026, opening 18 new positions and adding to 105 existing holdings. Its largest new stake was Cincinnati Financial: 26,740 shares worth $4.26M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, up from 50% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $5.36M trimmed.
- Thrive Capital Management (Pennsylvania)'s largest Q3 2026 buy was Cincinnati Financial: 26,740 shares worth $4.26M.
- Thrive Capital Management (Pennsylvania) added most to Vanguard Morningstar Value ETF in Q3 2026, an estimated $4.6M increase.
- Thrive Capital Management (Pennsylvania)'s biggest Q3 2026 reduction was Merck, cutting an estimated $5.36M.
- Thrive Capital Management (Pennsylvania) fully exited Kimberly-Clark in Q3 2026, selling an estimated $5.02M.
- Thrive Capital Management (Pennsylvania)'s ten largest holdings make up 27% of its $557M portfolio in Q3 2026.
- Thrive Capital Management (Pennsylvania) opened 18 new positions and closed 8 in Q3 2026.
- Thrive Capital Management (Pennsylvania)'s portfolio value rose 5.1% quarter-over-quarter to $557M.
Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q3 2026, filed 27 Oct 2026.